# Emergency Department-Initiated Medications for Alcohol Use Disorder

> **NCT05827159** · PHASE3 · RECRUITING · sponsor: **Yale University** · enrollment: 240 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Naltrexone Pill
- **DRUG:** Naltrexone Injection
- **BEHAVIORAL:** Brief Negotiation Interview
- **DRUG:** Gabapentin Pill

## Key facts

- **NCT ID:** NCT05827159
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-17
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827159, "Emergency Department-Initiated Medications for Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05827159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*